vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Investar Holding Corp (ISTR). Click either name above to swap in a different company.
Investar Holding Corp is the larger business by last-quarter revenue ($23.5M vs $13.8M, roughly 1.7× Gossamer Bio, Inc.). On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 0.9%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Investar Holding Corp is a U.S.-headquartered bank holding company that primarily operates across the Gulf Coast region. It delivers a full range of commercial and retail banking services, including deposit products, consumer and business loans, mortgage services, and wealth management solutions for individual clients, small and medium-sized enterprises, and commercial entities.
GOSS vs ISTR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $23.5M |
| Net Profit | $-47.2M | — |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 30.9% |
| Net Margin | -342.3% | — |
| Revenue YoY | 47.1% | 0.9% |
| Net Profit YoY | -43.0% | — |
| EPS (diluted) | $-0.21 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $23.5M | ||
| Q3 25 | $13.3M | $24.1M | ||
| Q2 25 | — | $22.3M | ||
| Q1 25 | — | $24.0M | ||
| Q4 24 | — | $23.3M | ||
| Q3 24 | — | $22.3M | ||
| Q2 24 | $95.8M | $20.4M | ||
| Q1 24 | $0 | $21.4M |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | $6.2M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $6.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | $49.2M | $4.1M | ||
| Q1 24 | $-41.9M | $4.7M |
| Q4 25 | -333.6% | 30.9% | ||
| Q3 25 | -369.4% | 31.0% | ||
| Q2 25 | — | 24.4% | ||
| Q1 25 | — | 32.2% | ||
| Q4 24 | — | 31.1% | ||
| Q3 24 | — | 27.6% | ||
| Q2 24 | 54.3% | 24.0% | ||
| Q1 24 | — | 28.5% |
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | 25.6% | ||
| Q2 25 | — | 20.2% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.1% | ||
| Q2 24 | 51.4% | 19.9% | ||
| Q1 24 | — | 22.0% |
| Q4 25 | $-0.21 | $0.50 | ||
| Q3 25 | $-0.21 | $0.54 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.61 | ||
| Q3 24 | — | $0.54 | ||
| Q2 24 | $0.22 | $0.41 | ||
| Q1 24 | $-0.19 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | — |
| Total DebtLower is stronger | — | $9.8M |
| Stockholders' EquityBook value | $-122.8M | $301.1M |
| Total Assets | $172.2M | $2.8B |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $354.5M | — | ||
| Q1 24 | $244.4M | — |
| Q4 25 | — | $9.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-122.8M | $301.1M | ||
| Q3 25 | $-82.3M | $295.3M | ||
| Q2 25 | — | $255.9M | ||
| Q1 25 | — | $251.7M | ||
| Q4 24 | — | $241.3M | ||
| Q3 24 | — | $245.5M | ||
| Q2 24 | $81.5M | $230.2M | ||
| Q1 24 | $26.7M | $227.0M |
| Q4 25 | $172.2M | $2.8B | ||
| Q3 25 | $208.8M | $2.8B | ||
| Q2 25 | — | $2.7B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $373.4M | $2.8B | ||
| Q1 24 | $259.4M | $2.8B |
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $18.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $18.2M | ||
| Q3 25 | $-36.2M | $6.9M | ||
| Q2 25 | — | $3.2M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | $15.9M | ||
| Q3 24 | — | $5.6M | ||
| Q2 24 | $116.3M | $2.8M | ||
| Q1 24 | $-52.3M | $7.8M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | 2.36× | 0.70× | ||
| Q1 24 | — | 1.66× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
